Catalent Newsroom

Barclays Maintains Catalent(CTLT.US) With Hold Rating, Maintains Target Price $63

Moomoo NewsNov 8 06:35 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: Catalent (CTLT), Moderna (MRNA) and HCA Healthcare (HCA)

TipRanksNov 8 06:23 ET

Jefferies Maintains Catalent(CTLT.US) With Hold Rating, Maintains Target Price $63.5

Moomoo NewsNov 6 08:40 ET

Catalent's Biologics Underperformance and PCH Stability Lead to Hold Rating

TipRanksNov 6 08:20 ET

Catalent Cut to Neutral From Outperform by Baird

Dow JonesSep 24 06:52 ET

Catalent Analyst Ratings

BenzingaSep 24 06:42 ET

Baird Downgrades Catalent(CTLT.US) to Hold Rating, Maintains Target Price $63.5

Moomoo NewsSep 24 05:32 ET

Hold Rating on Catalent Amid Deal Uncertainties and Conservative Financial Outlook

TipRanksSep 24 04:38 ET

Catalent Analyst Ratings

BenzingaJul 11 11:01 ET

RBC Capital Reiterates Sector Perform on Catalent, Maintains $63.5 Price Target

BenzingaJul 11 11:00 ET

Analysts Conflicted on These Healthcare Names: Lantheus (LNTH) and Catalent (CTLT)

TipRanksJul 11 06:42 ET

Catalent Analyst Ratings

BenzingaJun 28 11:44 ET

Barclays Adjusts Catalent Price Target to $63 From $47

MT NewswiresJun 27 07:20 ET

Catalent's Resilient Growth and Positive Outlook Reinforce Buy Rating

TipRanksMay 10 01:45 ET

RBC Capital Sticks to Their Hold Rating for Catalent (CTLT)

TipRanksMay 9 06:51 ET

Zacks Investment Research Downgrades Catalent to Underperform From Neutral, Price Target Is $48

MT NewswiresApr 12 10:37 ET

Analysts Offer Insights on Healthcare Companies: Catalent (CTLT), Vertex Pharmaceuticals (VRTX) and Alkermes (ALKS)

TipRanksApr 12 01:50 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: Catalent (CTLT), Alvotech (ALVO) and Immunocore Holdings (IMCR)

TipRanksApr 5 03:55 ET

Catalent Analyst Ratings

BenzingaApr 4 10:27 ET

Analysts Offer Insights on Healthcare Companies: Arbutus Biopharma (ABUS), Twist Bioscience (TWST) and Catalent (CTLT)

TipRanksMar 5 01:25 ET